These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 668810)

  • 21. Effects of lidocaine, procaine, procainamide and quinidine on electrophysiological properties of cultured embryonic chick hearts.
    Riccioppo Neto FR; Sperelakis N
    Br J Pharmacol; 1985 Dec; 86(4):817-26. PubMed ID: 4075018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subcellular and functional effects of quinidine, procaine amide, and lidocaine on rat myocardium.
    Harrow JA; Dhalla NS
    Can J Physiol Pharmacol; 1975 Dec; 53(6):1058-64. PubMed ID: 130965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of the effects of quinidine, diphenylhydantoin and disopyramide on the auricular refractory period in the anesthetized dog].
    DuchĂȘne-Marullaz P; Lapalus P; Lavarenne J; Combre A
    Arch Int Pharmacodyn Ther; 1974 Sep; 211(1):150-8. PubMed ID: 4460907
    [No Abstract]   [Full Text] [Related]  

  • 24. Membrane stabilising properties of the selective 5-HT2 receptor agonist, (+/-)-DOI.
    Martin KF; Kellett R; Buckett WR
    Eur J Pharmacol; 1991 Jul; 200(1):191-3. PubMed ID: 1769371
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions with the cardiac cholinergic system: effects of disopyramide and its mono-N-dealkylated metabolite.
    Boucher M; Chassaing C; Herbet A; DuchĂȘne-Marullaz P
    Life Sci; 1992; 50(20):PL161-6. PubMed ID: 1579041
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A new myocardial depressant and antifibrillatory agent.
    Johnson WE; Graeff DM; Martin AR; White AI
    Life Sci I; 1970 Apr; 9(8):471-6. PubMed ID: 5504264
    [No Abstract]   [Full Text] [Related]  

  • 27. Synthesis and anticholinergic properties of the enantiomers of 4-(isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide, the mono-N-dealkylated metabolite of disopyramide.
    Nelson WL; Sneed CK; Giacomini KM; Giacomini JC; Stauss J; Blaschke TF; Cox BM
    J Med Chem; 1981 May; 24(5):614-7. PubMed ID: 7241519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-adrenoceptor blocking and electrophysiological effects of bufetolol in the guinea pig atria.
    Inui J; Imamura H
    Eur J Pharmacol; 1977 Feb; 41(3):251-60. PubMed ID: 14011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequency and voltage-dependent effects of mono-N-dealkyldisopyramide, the major metabolite of disopyramide, in canine ventricular tissue.
    Toy W; Sasyniuk BI
    J Pharmacol Exp Ther; 1990 Aug; 254(2):603-11. PubMed ID: 2166798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative effect of imolamine, lidocaine and disopyramide on experimental rhythm disorders and auriculoventricular conduction.
    Junien JL; Lakatos CR; Tine J
    Arzneimittelforschung; 1974 Nov; 24(11):1743-7. PubMed ID: 4141258
    [No Abstract]   [Full Text] [Related]  

  • 31. Electrophysiological effects of the optical isomers of disopyramide and quinidine in the dog. Dependence on stereochemistry.
    Mirro MJ; Watanabe AM; Bailey JC
    Circ Res; 1981 Jun; 48(6 Pt 1):867-74. PubMed ID: 7226447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of HNS-32, a novel antiarrhythmic agent, on guinea-pig myocardium.
    Noguchi K; Kase J; Saitoh M; Masumiya H; Saitoh M; Nakazawa T; Tanaka Y; Tanaka H; Hashimoto K; Shigenobu K
    Pharmacology; 2002 Jan; 64(1):36-42. PubMed ID: 11731720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs.
    Wu B; Sato T; Kiyosue T; Arita M
    Cardiovasc Res; 1992 Nov; 26(11):1095-101. PubMed ID: 1291087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of disopyramide on electrophysiologic properties of canine cardiac purkinje fibers.
    Danilo P; Hordof AJ; Rosen MR
    J Pharmacol Exp Ther; 1977 Jun; 201(3):701-10. PubMed ID: 864604
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects on ventricular function of disopyramide, procainamide and quinidine as determined by radionuclide angiography.
    Wisenberg G; Zawadowski AG; Gebhardt VA; Prato FS; Goddard MD; Nichol PM; Rechnitzer PA; Gryfe-Becker B
    Am J Cardiol; 1984 May; 53(9):1292-7. PubMed ID: 6711431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemodynamic effects of disopyramide and procainamide in open-chest animals].
    Binetti G; Branzi A; Malini PL; Specchia S; Magelli C; Zannoli R; Magnani B
    G Ital Cardiol; 1978; 8(12):1314-9. PubMed ID: 738572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liquid-chromatographic determination of antidysrhythmic drugs: procainamide, lidocaine, quinidine, disopyramide, and propranolol.
    Kabra PM; Chen SH; Marton LJ
    Ther Drug Monit; 1981; 3(1):91-101. PubMed ID: 7233493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Time course of the electrophysiological effects of quinidine on canine cardiac Purkinje fibers: concentration dependence and comparison with lidocaine and disopyramide.
    Nattel S; Bailey JC
    J Pharmacol Exp Ther; 1983 Apr; 225(1):176-80. PubMed ID: 6834270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative class 1 electrophysiologic and anticholinergic effects of disopyramide and its main metabolite (mono-N-dealkylated disopyramide) in healthy humans.
    Bergfeldt L; Schenck-Gustafsson K; Dahlqvist R
    Cardiovasc Drugs Ther; 1992 Oct; 6(5):529-37. PubMed ID: 1450096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of the anticholinergic effect of SUN 1165 in comparison with flecainide, disopyramide and quinidine in single atrial myocytes isolated from guinea-pig.
    Inomata N; Ishihara T; Akaike N
    Br J Pharmacol; 1991 Dec; 104(4):1007-11. PubMed ID: 1810589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.